Company intelligence / Profile preview

Seekyo Therapeutics

Futuroscope / Poitiers area, Nouvelle-Aquitaine, Franceseekyo-therapeutics.com ↗

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

Seekyo Therapeutics has developed a proprietary platform called SKY™, enabling the design of "Tumor Activated Therapy™" that targets functional proteins in the tumor microenvironment. Their lead compound SKY01 has demonstrated efficacy and safety in both small and large animal models across several solid tumor types. The company remains pre-clinical with no human data yet reported but claims unprecedented antitumor efficacy versus standards of care in preclinical studies.

Therapeutic areas: Oncology
Modalities: Small molecules (cytotoxic drugs)Immuno-stimulants (immunotherapy agents)Antibody-drug conjugates (ADCs)
Industry: Biotech

Drug pipeline

2 assets

SKY01

Preclinical

1 more asset in the full pipeline.

Partnerships

Multiple partnerships with biotech and big pharma for ADC development and drug delivery systems targeting the tumor microenvironment; specific partner names not disclosed.

Beyond the preview

Go deeper on Seekyo Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seekyo Therapeutics.